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Objective: Oral leukoplakia is keratinized lesions in the buccal mucosa, tongue, and
gingiva. It is the most common oral precancerous lesion; oxidative stresses and irrele-
vant autophagy have been reported to be the cause of oncogenesis. p62, a cytoplasmic
protein induced by oxidative stress, is an adaptor protein involved in the formation of
protein aggregates and induction and inhibition of autophagy. The inhibition of
autophagy induces p62 overexpression and promotes oncogenesis via the oncogenic
signaling pathway. The aim of the present study was to elucidate the involvement of
intracellular expression of p62 in oral leukoplakia and to address its potential clinical
implementation as a biomarker to predict malignant transformation.
Material and Methods: Fifty samples from subjects with confirmed oral leukoplakia
were evaluated by immunohistochemical staining for the expression of p62, 8‐hydroxy‐
2′‐deoxyguanosine (8‐OHdG), Ki67, and p53. Univariate and multivariate logistic
regression analyses were performed to evaluate the association between p62, 8‐
OHdG, Ki67, and p53 and clinical characteristics, including epithelial dysplasia.
Results: Significant associations were observed between p62 expression in the
nucleus, p62 aggregation, and epithelial dysplasia (adjusted odds ratio [OR] = 5.75;
95% confidence interval [CI]: [1.28, 26.2]; .024 and OR = 6.16; 95% CI: [1.01,
37.4]; .048, respectively). The expression of p62 in the cytoplasm and the levels of
8‐OHdG, Ki67, and p53 were not significantly associated with epithelial dysplasia.
A significant relationship was found between p62 expression in the nucleus and
p53 expression (OR = 3.94; 95% CI: [1.14, 13.6]; .031).
Conclusions: The results suggested that p62 expression in the nucleus and p62
aggregation can be potential markers to predict the malignant transformation of oral
leukoplakia.
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Oral leukoplakia is keratinized lesions occurring in the buccal mucosa,
tongue, and gingiva.Oral leukoplakia, especially in the tongue, has a high
probability of transforming into malignancy (Bánóczy & Csiba, 1976).
The potential for malignant transformation of oral leukoplakia ranges
from 4.4% to 17.5% (Pindborg, Jølst, Renstrup, & Roed‐Petersen,
1968; Silverman, Gorsky, & Lozada, 1984). Oral leukoplakia is known
to be the most common oral precancerous lesion classified as an oral
potentially malignant disorder (Warnakulasuriya, Johnson, & van der
Waal, 2007). As it is important to predict the possibility of malignant
transformation and prognosis of oral leukoplakia, several attempts have
been made to identify specific molecular biomarkers. Recently, surgical
treatments underwent new considerations concerning the widespread
use of anticoagulant drugs in cardiovascular disease and became high‐
risk procedures (Isola et al., 2015).
Nagao et al. (2017) studied the expression of p53 and Ki67 in
response to chemoprevention of oral leukoplakia and reported that
the expression of p53 is inversely associated with the clinical response
to supplements administered for the condition. Studies have also
reported the biomarkers involved in oral leukoplakia (Nikitakis et al.,
2018), such as cornulin, keratin 4, keratin 13 (Schaaij‐Visser et al.,
2010), and podoplanin (de Vicente et al., 2013). Zamora et al. indicated
that the salivary 8‐OHdG level increased in patients with chronic peri-
odontitis and aggressive periodontitis. They also reported a positive
correlation between oxidative stress and increased micronuclei in
patients with periodontitis (Zamora‐Perez et al., 2015). This suggests
the association between oxidative stress and leukoplakia. In a research
on gene expression of malignant transformation, Ferlazzo et al. (2017)
reported that a methylenetetrahydrofolate reductase polymorphism
influenced DNA methylation and played an important role during oral
carcinogenesis. Additionally, Chaves et al. (2019) reported that the
levels of CD8+ cells increased in the oral premalignant region that later
became oral squamous cell carcinoma.
p62 is an oxidative stress protein implicated in the prognosis and
survival of various malignancies, including hepatocellular, breast, pros-
tate, ovarian, some gastrointestinal carcinomas, and melanoma.(Ruan
et al., 2017) Furthermore, it has been reported to be associated with
autophagy. p62 has been cloned as A170/Sequestosome/ZIP, and its
expression is induced by oxidative stress and other stresses. Previ-
ously, we cloned cDNA encoding a novel oxidative stress protein des-
ignated A170 from murine peritoneal macrophages (Ishii et al., 1996).
The ubiquitin‐ and LC3‐binding protein p62 regulates the formation of
protein aggregates, which is removed by autophagy. Therefore, the
inhibition of autophagy induces a marked cytoplasmic expression of
p62 (Komatsu et al., 2007). Recently, it has been reported that onco-
genic signaling is mediated by the expression of p62, promoting the
biogenesis and proliferation of cancer. Furthermore, recent studies
have indicated abnormal overexpression of p62 in oral squamous car-
cinoma cells, and this might be the main cellular defense mechanism
against cancer therapy (Inui et al., 2013). Overexpression of p62 was
more obvious in oral carcinoma than in low‐grade dysplasia or
nonepithelial dysplasia. Overexpression of p62 can cause low‐gradedysplasia in the oral epithelium, which can develop into carcinoma
via resistance to various oxidative stresses (Inui et al., 2013). Histolog-
ically, epithelial dysplasia is indicated as one of the factors involved in
the carcinogenesis of oral leukoplakia.
If it is proved that p62 expression and epithelial dysplasia are sig-
nificantly correlated, this could lead to the implementation of p62 as
a marker predicting malignant transformation that could be applied
clinically, which would substantially improve the treatment and diag-
nosis of oral leukoplakia.
The aim of the present study was to elucidate the involvement of
intracellular expression of p62 in oral leukoplakia. We evaluated the
intracellular expression of p62 in oral leukoplakia tissue specimens
and compared various clinical characteristics, such as the intracellular
expression of p62 and dysplasia in the oral epithelium, as well as other
biomarkers including 8‐hydroxy‐2′‐deoxyguanosine (8‐OHdG), Ki67,
and p53 associated with oral leukoplakia.2 | MATERIAL AND METHODS
2.1 | Samples
Fifty formalin‐fixed, paraffin‐embedded blocks prepared from speci-
mens of Japanese Asian patients with pathologically diagnosed oral
leukoplakia who visited four city hospitals (viz., Aichi‐Gakuen Univer-
sity School of Dentistry, Okazaki City Hospital, Aichi Saiseikai Hospi-
tal, and Yokkaichi Municipal Hospital) from 1991 to 2015 were
retrospectively collected in Japan. Clinical information and clinicopath-
ological data were obtained from medical records. Patients with oral
leukoplakia included 24 males (48%) and 26 females (52%) with a
median age of 68 (28–95 years). The clinical‐demographic characteris-
tics of the study participants, along with data regarding the presence
or absence of epithelial dysplasia, are presented in Table 1. The oral
leukoplakia specimens were harvested from the tongue (18 cases;
36%) and other areas (32 cases; 64%); 24 of 50 patients (48%) were
smokers (two patients were not examined), and 18 (36%) were
habitual alcohol drinkers (one patient was not examined). The number
of patients with epithelial dysplasia was 18 (36%). The number of
patients with single occurrence lesions was 43 (86%), and the number
of patients with multiple occurrence lesions was 7 (14%).
The relevant data were collected from clinical and pathological
records after obtaining written consent from the patients and approval
by the Ethics Committee of Aichi‐Gakuin Dental Hospital, Nagoya,
Japan (approval number 39). This study was performed in compliance
with the Declaration of Helsinki.2.2 | Immunohistochemical staining
2.2.1 | p62 staining
All the specimens were serially sectioned to a thickness of 4 μm. After
deparaffinization, the tissue sections were pretreated with 10 mmol/L
of sodium citrate buffer (pH 6.0) in a microwave oven for 5 min at
TABLE 1 Clinical characteristics (number of cases and %)
Characteristics Number of cases (%)
Age
≤64 20 (40)
≥65 30 (60)
Sex
Male 24 (48)
Female 26 (52)
Location
Tongue 18 (36)
Others 32 (64)
Occurrence form
Single 43 (86)
Multiple 7 (14)
Drinking
Yes 18 (36)
No 31 (62)
Not examined 1 (2)
Smoking
Yes 24 (48)
No 24 (48)
Not examined 2 (4)
Epithelial dysplasia
Positive 18 (36)
Negative 32 (64)
YOSHIDA ET AL. 39195°C. The sections were then incubated in a mixture of 0.3% hydro-
gen peroxide solution in 100% methanol for 20 min to quench endog-
enous peroxidase activity. After washing with phosphate‐buffered
saline, the sections were incubated overnight at 4°C with the primary
antibodies for p62 (1:100; SQSTM1, ab56416; Abcam, Cambridge,
UK). After incubation, the sections were rinsed with phosphate‐
buffered saline and treated with the secondary antibody (Vector Lab-
oratories, Burlingame, CA) for 30 min, followed by color development
using 3,3′‐diaminobenzidine tetrahydrochloride (DAB; Cell Signaling
Technology, Tokyo, Japan) to detect antigen–antibody binding, and
hematoxylin was applied for 1 min to counterstain the nuclei. Epithe-
lial cells from the plantar of mice were used as positive control. The
samples stained without the primary antibody were used as negative
control.
2.2.2 | 8‐OHdG staining
All the specimens were serially sectioned to a thickness of 4 μm. After
deparaffinization, the tissue sections were pretreated with 10 mmol/L
of sodium citrate buffer (pH 6.0) in a microwave oven for 20 min at
90°C. However, 0.3% hydrogen peroxide solution was not used
because 8‐OHdG has a specific immune stainability for the nucleus.
After washing with phosphate‐buffered saline, the sections wereincubated overnight at 4°C for 6–12 hr with the primary antibody
(1:200 anti‐8‐hydroxy‐2′‐deoxyguanosine antibody, cloneN45.1;
JaICA, NIKKEN SEIL, Tokyo, Japan). After incubation, the sections
were rinsed with phosphate‐buffered saline and treated with the
secondary antibody (Vector Laboratories, Burlingame, CA) for
30 min, followed by color development using 3,3′‐diaminobenzidine
tetrahydrochloride (DAB; Cell Signaling Technology, Tokyo, Japan)
for 30 min to detect antigen–antibody binding, and hematoxylin was
applied for 20 s to 1 min to counterstain the nuclei. Epithelial cells
from the plantar of mice were used as positive control. After setting
the conditions, immunohistochemical staining was performed using
an automated immunostainer (Histostainer48A; Nichirei Biosciences
Inc., Tokyo, Japan).
2.2.3 | Ki67 and p53 staining
Samples were immunostained for Ki67 (Dako monoclonalmouse Clone
MIB‐1; Dako, Glostrup, Denmark) and p53 (Dako monoclonalmouse
Clone DO‐7; Dako) using an automated immunostainer (Dako
Autostainer Link; Dako) by the standard streptavidin‐biotin‐peroxidase
method (Dako EnVision FLEX kit; Dako, Glostrup, Denmark). The
antigen‐retrieval technique included high‐temperature heating in a
microwave oven for 10 and 5 min for Ki67 and p53, respectively.
2.2.4 | Evaluation of expression of p62, 8‐OHdG,
Ki67, and p53
The stained sections were independently evaluated by one oral
pathologist (S.M.), and three oral surgeons (T.Y., T.T., and H.N.)
blindfolded. We evaluated the expression of p62, 8‐OHdG, and
p53 in the mucosal epithelium and the expression of Ki67 in the
basal or suprabasal layer. Although both strong and weak expres-
sions were observed, we only judged the specimens as either posi-
tive or negative. Epithelial cells from the plantar of mice were used
as positive control. Samples stained without the primary antibody
were used as the negative control. Representative features are
shown in Figures 1 and 2.
All immunohistochemical markers were assessed by light micros-
copy (BZ‐X700 All‐in‐One Fluorescence Microscope; KEYENCE,
Osaka, Japan). The areas showing the expression of representative
markers in the sections were chosen at a low‐powered field (100×),
and then evaluated at middle‐ and high‐powered fields (200× and
400×, respectively). Three oral surgeons (T.Y., T.T., and H.N.)
blindfolded and independently counted the positive cells for each
marker and calculated the positive cell occupancy rate to identify the
cutoff value, considering each receiver‐operating characteristic. We
evaluated the markers in each sample at levels of 1%, 10%, 20%,
30%, and 50% positivity by the mean value of the positive cell occu-
pancy rate and constructed the corresponding class values, histo-
grams, box plots, and receiver operating characteristic curves. We
differentiated nuclear and cytoplasmic expression of p62 because dif-
ferences in p62 localization indicate other conditions (Komatsu et al.,
2010). Positive expression of nuclear p62 was defined as p62 staining
FIGURE 1 Immunohistochemical staining of (a) 8‐OHdG, (b) Ki67, (c) p53, and (d) p62 in oral leukoplakia tissue specimens. Representative
sections showing positive expression of the four proteins. Magnification: 200×. (d) Section showing positive expression of p62 in the nucleus
and cytoplasm
FIGURE 2 Immunohistochemical staining of (a) 8‐OHdG, (b) Ki67, (c) p53, and (d) p62 in oral leukoplakia tissue specimens. Representative
sections showing negative expression of the four proteins. Magnification: 200×. (d) Section showing negative expression of p62 in the nucleus
and cytoplasm
392 YOSHIDA ET AL.in the nuclei. A cutoff value of 20% was used to group cases with cells
presenting positive expression of nuclear p62. With respect to p62
aggregation, ≥1 dot per cell in more than 1% of the oral leukoplakia
tissue at 200× and 400× magnification fields was defined as positiveexpression, and other results were defined as negative expression.
Thus, a cutoff value of 1% was used to group cases presenting p62
aggregation. Positive expression of cytoplasmic p62 was defined as
p62 staining in the cytoplasm. A cutoff value of 20% was used to
TABLE 2 Epithelial dysplasia and other clinical parameters
Characteristics Odds ratio 95% CI P value
Univariate logistic regression analysis
Age
≦64 vs. ≦65 1.91 [0.59, 6.20] .282
Sex
Male vs. female 3.33 [0.99, 11.22] .052
Location
Tongue vs. others 3.57 [1.03, 12.43] .046*
YOSHIDA ET AL. 393group cases with cells presenting positive expression of cytoplasmic
p62. If 8‐OHdG staining was observed in the nuclei, we judged the cell
as a positive expression cell. Positive expression of nuclear p53 was
defined as nuclear positivity for p53 in the epithelium and positive
expression of Ki67 was defined as nuclear positivity for Ki67 in the
basal or suprabasal layer. A minimum of 1,000 cells were counted
under 200× and 400× magnifications in areas showing the expression
of representative markers in each section. Similarly, we used a cutoff
values of 50%, 10%, and 1% for 8O‐HdG, Ki67, and p53 positive cells,
respectively. Positive cell occupancy rate of each maker is shown in
Figures S1 and S2.
Occurrence form
Single vs. multiple 0.36 [0.07, 1.84] .221
Drinking
Yes vs. no 2.44 [0.73, 8.17] .146
Smoking
Yes vs. no 2.05 [0.62, 6.76] .236
Multivariate logistic regression analysis
Age
≦64 vs ≦65 1.76 [0.43, 7.18] .434
Sex
Male vs. female 3.23 [0.43, 24.40] .2572.3 | Statistical analyses
We performed univariate and multivariate logistic regression analyses to
evaluate the association between epithelial dysplasia and other clinical
characteristics. We also performed a logistic regression analysis to
estimate the association between epithelial dysplasia and each
biomarker in oral leukoplakia tissue samples. We performed a univariate
logistic regression analysis to assess the relationship between p62
expression and aggregation and other biomarkers. Results with P values
<.05 were considered statistically significant. All statistical analyses were
performed with JMP® 13 for WIN (SAS Institute Inc., Cary, NC, USA).
Location
Tongue vs. others 2.45 [0.59, 10.20] .220
Occurrence form
Single vs. multiple 0.41 [0.06, 2.75] .361
Drinking
Yes vs. no 1.00 [0.18, 5.49] .998
Smoking
Yes vs. no 1.55 [0.19, 12.36] .681
*P < 0.05 significant.3 | RESULTS
The clinicopathological characteristics including age, gender, location,
occurrence type, drinking habit, smoking habit, and epithelial dysplasia
are shown inTable 1. The relationship between epithelial dysplasia and
clinical characteristics is shown in Table 2. The number of epithelial
dysplasia (+) samples was as follows: in patients aged ≤64: 9 of 20
(45%), in those aged ≥65: 9 of 30 (30%); in males: 12 of 24 (50%),
in females: 6 of 26 (23%); in the tongue region: 11 of 18 (61%), in
other regions: 7 of 32 (22%); in patients with single occurrence: 14
of 43 (32%), in those with multiple occurrence: 4 of 7 (57%); in
patients with drinking habit: 9 of 18 (50%), in those with no drinking
habit: 9 of 32 (28%); in smokers: 11 of 24 (46%), in nonsmokers: 7
of 26 (27%). There was a significant association between epithelial
dysplasia and location in the univariate logistic regression analysis
(.046), but there was no significant relationship between epithelial
dysplasia and other clinicopathological characteristics in the multivariate
analysis (Table 2). The results confirmed that other clinical characteristics
did not affect epithelial dysplasia (data not shown).
The relationships between epithelial dysplasia and each biomarker
are shown in Table 3. With respect to the number of epithelial
dysplasia (+) samples, the following was observed: nuclear p62 (−): 7 of
29 (24%); nuclear p62 (+): 11 of 21 (52%); p62 aggregation (−): 10 of 36
(28%); p62 aggregation (+): 8 of 14 (57%); cytoplasmic p62 (−): 7 of 21
(33%); cytoplasmic p62 (+): 11 of 29 (38%); 8‐OHdG (−): 4 of 18 (22%);
8‐OHdG (+): 14 of 32 (44%); Ki67 (−): 14 of 40 (35%); Ki67 (+): 4 of
10 (40%); p53 (−): 6 of 21 (29%); and p53 (+): 12 of 29 (41%). There
was a significant association between epithelial dysplasia and p62 inthe nucleus in the univariate logistic regression analysis (.044).
Furthermore, there was a significant association between epithelial
dysplasia and p62 in the nucleus (.024) and p62 aggregation (.048) in
the multivariate analysis.
The relationships between p62 parameters (p62 in the nucleus, p62
aggregation, and p62 in the cytoplasm) and other biomarkers (8‐OHdG,
Ki67, and p53) are shown inTable 4. There was a significant association
between p62 in the nucleus and p53 (.031). The results indicated that
p62 expression in the nucleus and p62 aggregation were significantly
associated with the occurrence of epithelial dysplasia.4 | DISCUSSION
In the present study, we found that the association between the
intracellular expression of p62 and the presence of epithelial dysplasia
and other clinical characteristics are involved in oral leukoplakia. The
univariate analysis showed a significant association between epithelial
dysplasia and location (P < .05), but the multivariate analysis showed
no significant relationship between epithelial dysplasia and other
TABLE 4 Univariate logistic regression analysis in association with
p62 parameters and other biomarkers
Parameter Odds ratio 95% CI P value
p62 in nucleus
8‐OHdG 2.60 [0.75, 9.01] .132
Ki67 4.33 [0.97, 19.43] .055
p53 3.94 [1.14, 13.65] .031*
p62 aggregation
8‐OHdG 1.59 [0.42, 6.07] .497
Ki67 2.00 [0.47, 8.56] .350
p53 3.67 [0.87, 15.38] .076
p62 in cytoplasm
8‐OHdG 1.67 [0.52, 5.36] .392
Ki67 3.62 [0.68, 19.21] .131
p53 2.09 [0.66, 6.59] .354
*P < 0.05 significant.
TABLE 3 Logistic regression analysis in association with dysplasia
and each biomarker
Parameter Odds ratio 95% CI P value
Univariate logistic regression analysis
p62 in nucleus 3.46 [1.02, 11.56] .044*
p62 aggregation 3.47 [0.96, 12.54] .058
p62 in cytoplasm 1.22 [0.38, 3.97] .738
8‐OHdG 2.72 [0.73, 10.11] .135
Ki67 1.24 [0.30, 5.13] .769
p53 1.76 [0.53, 5.87] .354
Multivariate logistic regression analysis
p62 in nucleus 5.75 [1.26, 26.19] .024*
p62 aggregation 6.16 [1.01, 37.42] .048*
p62 in cytoplasm 1.90 [0.42, 8.62] .403
8‐OHdG 5.31 [0.96, 29.46] .056
Ki67 1.46 [0.27, 7.76] .658
p53 2.35 [0.57, 9.76] .240
*P < 0.05 significant.
394 YOSHIDA ET AL.clinicopathological characteristics (Table 2); these results confirmed
that other clinical characteristics did not affect epithelial dysplasia.
The univariate analysis showed a significant association between
epithelial dysplasia and p62 in the nucleus (P < .05), and the multivariate
analysis showed that the positive nuclear p62 expression and the
positive p62 aggregation groups included the epithelial dysplasia group
of oral leukoplakia (P < .05; Table 3). Considering these results and by
removing the confounding factors, it was clarified that the aberrant
expression of nuclear p62 and p62 aggregation affect the occurrence
of epithelial dysplasia. The pathogenesis and epidemiological explanation
of oral leukoplakia have been previously described (Leemans, Braakhuis,
& Brakenhoff, 2011).The oral mucosal epithelium is often exposed to various stresses,
including tobacco, alcohol, periodontal disease, and other inflamma-
tions, salt, stimulant luxury goods, and other environmental and life-
style stresses (Nagao et al., 2016; Petti, 2009). Several causal factors
for oral leukoplakia are known; these include smoking, excess alcohol
drinking, betel quid chewing, and chronic infections by fungi and
viruses (Petti, 2009). It was reported that periodontitis increased the
risk of oral leukoplakia and mucosal lesions, thus predisposing to oral
cancers (Meisel, Holtfreter, Biffar, Suemnig, & Kocher, 2012).
Dental prosthesis and restorations have been reported in associa-
tion with oral leukoplakia as risk factors in Japanese subjects (Nagao
et al., 2016). It has been suggested that these stresses might be
sources of massive quantities of reactive oxygen species, which have
been clearly recognized as etiologic factors of precancerous progres-
sion, as damage to cells easily accumulates. These changes alter the
oxidant–antioxidant status of various clinical stages of oral leukoplakia
presumably (Srivastava, Austin, Shrivastava, & Pranavadhyani, 2014). If
oxidative stress and other stresses accumulate in the oral mucosa,
intracellular homeostasis might be altered, and autophagy might be
impaired (Żukowski, Maciejczyk, & Waszkiel, 2018).
Kiffin, Bandyopadhyay, and Cuervo (2006) reported that mild oxi-
dative stress promotes successful autophagy to facilitate the elimina-
tion of damaged organelles, but acute or persistent oxidative stress
induces an intracellular increase in reactive oxygen species, which
injure the lysosomal membrane and disturb the formation of
autophagosomes. If autophagy is not functional or the oxidative stress
damage exceeds autophagy, aberrant and altered intracellular oxidized
components (including p62) are accumulated in cells. In oral leukopla-
kia lesions, a similar response to oxidative injury might occur as part of
cellular defense systems (Kiffin et al., 2006). We can hypothesize
another association between oxidative stress and autophagy. Under
basal conditions, the Nrf2–Keap1 pathway functions as a critical reg-
ulator of cellular defense mechanisms against oxidative stress (Lau
et al., 2010). p62 interacts with the Nrf2‐binding site on Keap1, and
overexpression of p62 or autophagy deficiency results in a competi-
tion between Nrf2 and p62 for Keap1, resulting in the stabilization
of Nrf2 and transcriptional activation of the antioxidant response ele-
ment, including p62 (Komatsu et al., 2010). Such consecutive reactions
break the loop, and p62 creates a positive feedback loop in the
Keap1–Nrf2 pathway (Jain et al., 2010). This noncanonical mechanism
of Nrf2 might explain p62 nuclear overexpression and p62 aggrega-
tion during oral leukoplakia under acute or persistent oxidative stress
conditions.
In the present study, we speculated that similar intracellular reac-
tions occurred in the mucosal epithelium of oral leukoplakia and that
p62 expression in the nucleus and p62 aggregation were increased
in epithelial dysplasia lesions.
Recently, molecular biology approaches have been employed to
clarify the mechanism of malignant transformation and identify several
risk factors of malignancy as biomarkers, but there are only a few
reports concerning autophagy‐related markers (Nikitakis et al., 2018).
Lévy et al. (2015) analyzed the levels of p62 to investigate the sta-
tus of autophagy in intestinal epithelial cells during malignant
YOSHIDA ET AL. 395transformation in adenomatous polyposis coli. They indicated that the
inhibition of autophagy in the intestinal epithelium impaired the devel-
opment and progression of tumors in patients with a high risk of
tumorigenesis of colorectal cancer. Further, they indicated the impor-
tant role of the microbiota in the antitumor effects of autophagy
inhibition.
It has been shown that the ubiquitin/LC3‐binding protein p62 has
a key role as a regulator of selective autophagy, as it is involved in
both ubiquitinated antigen and LC3 (Komatsu et al., 2010; Ruan
et al., 2017). Furthermore, it is necessary to sequester short‐lived pro-
teins into the autophagosomes (Twitty, Jensen, Hu, & Fox, 2011).
Terabe et al. (2018) reported that excessive accumulation of
autophagy‐related proteins LC3A, LC3B, and p62 in normal mucosa
near the surgical margin is a useful marker for local recurrence and
associated poor prognosis. They clarified that the expression of
LC3A and LC3B correlated with tumor recurrence and poor prognosis
and the expression of p62 correlated with tumor recurrence. There-
fore, they recommended that if these proteins are detected in normal
mucosa near the surgical margin, strict follow‐up observation should
be made or additional resection should be considered (Terabe et al.,
2018). Otherwise, p62 can be considered as a target at the interface
of aging, autophagy, and age‐related diseases (Bitto et al., 2014). p62
might be associated with various diseases, and it can be a potential
biomarker of prognosis and survival of various malignancies induced
by autophagy and oxidative stress.
The wild‐type p53 protein is degraded rapidly in cells, but the p53
mutant proteins possess an extended half‐life and accumulate in the
cells. We can speculate that the presence of an abnormal p53 gene
results in the occurrence of the p53 mutant proteins (Hussain &
Harris, 1998). The accumulation of p53 mutant proteins has been
investigated, and frequent p53 gene mutations are likely closely
involved in the carcinogenesis of oral squamous cell carcinoma.(Sakai
& Tsuchida, 1992) It is generally believed that p53 overexpression is
significantly higher in oral leukoplakias that transform into cancer
and that epithelial dysplasia is derived from p53‐mutated stem cells
(Braakhuis, Leemans, & Brakenhoff, 2004). In the present study, an
unknown causal relationship was observed between the nuclear p62
expression and p53 expression with epithelial dysplasia.
It is important to predict the possibility of malignant transforma-
tion and prognosis for various treatments of oral leukoplakia
including surgery. Various causal factors for oral leukoplakia have
been considered; these include smoking, excess alcohol drinking,
betel quid chewing, and chronic infections like periodontitis. The
mechanisms of malignant transformation have been investigated by
many researcher; however, they have not been completely eluci-
dated yet.
Therefore, several attempts are being made to identify specific
molecular biomarkers to predict lesions that have the potential to
transform into malignancy, as these criteria are beneficial to make
a decision for the removal of lesions. There are a few reports that
have demonstrated the significant association between nuclear p62
expression and p62 aggregation and epithelial dysplasia in oral
leukoplakia.Our results suggest that the intracellular expression of p62‐related
biomarkers in the oral leukoplakia lesions has the potential to be
developed as a tumor malignant transformation marker. Recently,
aberrant intracellular expression of p62 has been identified in various
solid tumors, including hepatocellular, breast, ovarian, prostate, oral,
some gastrointestinal carcinomas, and melanoma (Ruan et al., 2017).
Therefore, it has been considered that the inhibition of autophagy
induces a marked cytoplasmic expression of p62 (Komatsu et al.,
2007). Intracellular metabolism inhibition via p62 results in abnormal
intracellular expression of genes, leading to tumorigenesis. A similar
mechanism has been inferred in the malignant transformation of oral
leukoplakia.
Due to the small sample size of this study, it is difficult to interpret
the data for future clinical trials. We did not obtain quantitative data
regarding each biomarker and immunohistochemistry was the only
method used to evaluate p62 expression in human specimens (Ruan
et al., 2017). However, to the best of our knowledge, there are no
reports that indicate a significant association between p62 nuclear
expression, p62 aggregation, and dysplasia in oral leukoplakia. In the
present study, we showed that the expression of p62 is associated
with dysplasia in oral leukoplakia. We have elucidated the clinical
implementation of p62 as a biomarker to predict malignant transfor-
mation of oral leukoplakia. Nevertheless, we investigated only p62
expression in oral leukoplakia, but there are other autophagy‐related
markers, such as LC3A/B, associated with poor prognosis in oral squa-
mous cell carcinoma (Terabe et al., 2018). Further investigations are
expected to clarify the malignant transformation mechanisms, eluci-
date the interactions among biomarkers, and identify new biomarkers.
In the future, well‐designed studies should investigate potential
biomarkers to predict malignant transformation of oral leukoplakia to
improve the treatment and diagnosis of oral premalignant lesions.
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